Following acute SclAb treatment, osteoblast and osteoblast precursor markers of SP7, RUNX2, BGLAP, and COL1A1 were upregulated to or above non‐OI untreated control levels in OI type III samples. This evidence concerns the gene RUNX2 and osteogenesis imperfecta.